Use of sulfobutyl ether β-cyclodextrin as a vehicle for D-threo-1-phenyl-2-decanoylamino-3-morpholinopropanol-related glucosylceramide synthase inhibitors

被引：5

作者：

Abe, A ^{[1
]}

Gregory, S ^{[1
]}

Lee, L ^{[1
]}

Shayman, JA ^{[1
]}

机构：

[1] Univ Michigan, Sch Med, Dept Internal Med, Div Nephrol, Ann Arbor, MI 48109 USA

来源：

ANALYTICAL BIOCHEMISTRY | 2000年 / 287卷 / 02期

关键词：

D O I：

10.1006/abio.2000.4874

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

页码：344 / 347

页数：4

共 9 条

[1] Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation [J].

Abe, A ;

Gregory, S ;

Lee, L ;

Killen, PD ;

Brady, RO ;

Kulkarni, A ;

Shayman, JA .

JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1563-1571

[2]

ABE A, 1995, J LIPID RES, V36, P611

[3] Glycosphingolipid depletion in Fabry disease lymphoblasts with potent inhibitors of glucosylceramide synthase [J].

Abe, A ;

Arend, LJ ;

Lee, L ;

Lingwood, C ;

Brady, RO ;

Shayman, JA .

KIDNEY INTERNATIONAL, 2000, 57 (02) :446-454

[4] BIOMIMETIC CHEMISTRY AND ARTIFICIAL ENZYMES - CATALYSIS BY DESIGN [J].

BRESLOW, R .

ACCOUNTS OF CHEMICAL RESEARCH, 1995, 28 (03) :146-153

[5] Improved inhibitors of glucosylceramide synthase [J].

Lee, L ;

Abe, A ;

Shayman, JA .

JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :14662-14669

[6] PRELIMINARY SAFETY EVALUATION OF PARENTERALLY ADMINISTERED SULFOALKYL ETHER BETA-CYCLODEXTRIN DERIVATIVES [J].

RAJEWSKI, RA ;

TRAIGER, G ;

BRESNAHAN, J ;

JABERABOANSARI, P ;

STELLA, VJ ;

THOMPSON, DO .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1995, 84 (08) :927-932

[7]

Shayman JA, 2000, METHOD ENZYMOL, V311, P373

[8]

Stella V. J, 1996, P 8 INT S CYCL, P471

[9]

VUNNAM RR, 1980, CHEM PHYS LIPIDS, V26, P265

← 1 →